Entity Details

Primary name MUSK
Entity type gene
Source Source Link

Details

PrimaryID4593
RefseqGeneNG_016016
SymbolMUSK
Namemuscle associated receptor tyrosine kinase
Chromosome9
Location9q31.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-27
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsMUSK_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001934 positive regulation of protein phosphorylation
GO:0004713 protein tyrosine kinase activity
GO:0004714 transmembrane receptor protein tyrosine kinase activity
GO:0005518 collagen binding
GO:0005524 ATP binding
GO:0005887 integral component of plasma membrane
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0007275 multicellular organism development
GO:0007528 neuromuscular junction development
GO:0007613 memory
GO:0008582 regulation of synaptic assembly at neuromuscular junction
GO:0010628 positive regulation of gene expression
GO:0030154 cell differentiation
GO:0031594 neuromuscular junction
GO:0033674 positive regulation of kinase activity
GO:0038062 protein tyrosine kinase collagen receptor activity
GO:0043235 receptor complex
GO:0045211 postsynaptic membrane
GO:0046777 protein autophosphorylation
GO:0046872 metal ion binding
GO:0071340 skeletal muscle acetylcholine-gated channel clustering
GO:2000541 positive regulation of protein geranylgeranylation

Diseases

Show/Hide Table
Disease IDSourceNameDescription
208150 OMIMFetal akinesia deformation sequence 1 (FADS1)A clinically and genetically heterogeneous group of disorders with congenital malformations related to impaired fetal movement. Clinical features include fetal akinesia, intrauterine growth retardation, polyhydramnios, arthrogryposis, pulmonary hypoplasia, craniofacial abnormalities, and cryptorchidism. FADS1 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.
616325 OMIMMyasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency (CMS9)A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS9 is a disorder of postsynaptic neuromuscular transmission, due to deficiency of AChR at the endplate that results in low amplitude of the miniature endplate potential and current. The disease is caused by variants affecting the gene represented in this entry. MUSK mutations lead to decreased agrin-dependent AChR aggregation, a critical step in the formation of the neuromuscular junction.